SPOTLIGHT -
FDA authorizes Ito Invivyd’s pemivibart (Pemgarda), insights on Sofosbuvir levels in pregnant women, the effectiveness of fidaxomicin vs vancomycin for CDI treatment, and more this week from Contagion.
Tracking the Evolution of Clostridioides difficile and Implications for Healthcare
C difficile, Antimicrobials, and the Patients Most Affected
Clostridioides Difficile Infection Testing Patterns and Outcomes Following Laxative Administration
CDC Strategies Tested for Preventing Hospital-Onset C difficile
C Diff Advocacy Organization Announces its National Summit Agenda
Community Acquired Pneumonia Often Inappropriately Diagnosed in Hospital Admissions